Literature DB >> 14768790

Outcomes of very low birth weight infants in a newborn tertiary center in Turkey, 1997-2000.

Begüm Atasay1, Ayla Günlemez, Sevim Unal, Saadet Arsan.   

Abstract

Our purpose was to determine mortality and morbidity rates and selected outcome variables for infants weighing less than 1500 g, who were admitted to the neonatal intensive care unit of our hospital from 1997 to 2000. The ultimate goal of the study was to define a model for developing a regional database. Information on all very low birth weight (VLBW) admissions to a tertiary level neonatal intensive care unit (NICU) in Ankara between January 1997 and December 2000 was prospectively collected by three neonatologists using a standard manual of operation and definitions. The data consisted of patient information including sociodemographic characteristics; antenatal history; mode of delivery; APGAR scores; need for resuscitation; admission illness severity (Clinical Risk Index for Babies-CRIB) and therapeutic intensity (Neonatal Therapeutic Intensity Scoring System-NTISS); selected NICU parameters and procedures such as respiratory support, surfactant therapy, and postnatal corticosteroid therapy; and selected patient outcomes such as intraventricular hemorrhage, septicemia, necrotizing enterecolitis, retinopathy of prematurity, and chronic lung disease. The number of VLBW admissions to the NICU was 133, with 51 (28.6%) referrals from other maternity centers. The mean birth weight and gestational age of the infants were 1175 +/- 252 g and 30.3 +/- 2.9 weeks, respectively. One hundred and seventeen of 133 cases (88.7%) received at least one antenatal care visit. The median CRIB and NTISS scores were 4.5 and 31, respectively. Antenatal steroids had been given to 74 (55.6%) infants. Surfactant treatment and respiratory support were given to 33 (24.8%) and 73 (54.8%) infants, respectively. Among selected outcomes, chronic lung disease (CLD), threshold retinopathy of prematurity (ROP), severe intraventricular hemorrhage (IVH > or = grade III), nosocomial infection and necrotizing enterocolitis (NEC) were encountered in 14 (12.6%), 9 (8.1%), 3 (2.2%), 34 (25.5%) and 35 (26.3%) of the infants, respectively. Overall survival rate was 83.5% (111/133); most of the deceased cases were under 750 g (12/22). It was prospectively shown that 111 (100%) of the surviving infants could be regularly followed in a newborn follow-up clinic to provide health maintenance, developmental assessment and support. Compared with reports from other developing countries, VLBW infants at our center had higher survival rates. Compared to developed countries, survival rate was lower, especially for extremely very low birth weight infants. There is interaction between birth weight and survival rate. Among selected neonatal outcomes, chronic lung disease, threshold retinopathy, severe intraventricular hemorrhage (IVH > or = grade III) and nosocomial infection rates at this center were comparable with some reports from developed nations.

Entities:  

Mesh:

Year:  2003        PMID: 14768790

Source DB:  PubMed          Journal:  Turk J Pediatr        ISSN: 0041-4301            Impact factor:   0.552


  7 in total

Review 1.  Challenges of management and outcome of neonatal surgery in Africa: a systematic review.

Authors:  Sebastian O Ekenze; Obinna V Ajuzieogu; Benedict C Nwomeh
Journal:  Pediatr Surg Int       Date:  2016-01-18       Impact factor: 1.827

2.  Reducing length of stay in hospital for very low birthweight infants by involving mothers in a stepdown unit: an experience from Karachi (Pakistan).

Authors:  Zulfiqar A Bhutta; Iqtidar Khan; Suhail Salat; Farukh Raza; Husan Ara
Journal:  BMJ       Date:  2004-11-13

3.  Early outcome of preterm infants with birth weight of 1500 g or less and gestational age of 30 weeks or less in Isfahan city, Iran.

Authors:  Fakhri Navaei; Banafsheh Aliabady; Javad Moghtaderi; Masoud Moghtaderi; Roya Kelishadi
Journal:  World J Pediatr       Date:  2010-06-12       Impact factor: 2.764

Review 4.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

5.  Determinants of survival in very low birth weight neonates in a public sector hospital in Johannesburg.

Authors:  Daynia E Ballot; Tobias F Chirwa; Peter A Cooper
Journal:  BMC Pediatr       Date:  2010-05-06       Impact factor: 2.125

6.  Mortality in extremely low-birth-weight neonates in méxico city (1985-2009).

Authors:  José Iglesias-Leboreiro; Isabel Bernardez-Zapata; José Ramírez-Haua; Rocco González-Morán; Mario Enrique Rendón-Macías
Journal:  Int J Pediatr       Date:  2010-12-21

7.  Early neonatal outcomes of very-low-birth-weight infants in Turkey: A prospective multicenter study of the Turkish Neonatal Society.

Authors:  Esin Koc; Nihal Demirel; Ahmet Yagmur Bas; Dilek Ulubas Isik; Ibrahim Murat Hirfanoglu; Turan Tunc; Fatma Nur Sari; Guner Karatekin; Ramazan Ozdemir; Huseyin Altunhan; Merih Cetinkaya; Beyza Ozcan; Servet Ozkiraz; Sebnem Calkavur; Kadir Serafettin Tekgunduz; Ayhan Tastekin; Ferda Ozlu; Banu Mutlu Ozyurt; Ahmet Ozdemir; Bilin Cetinkaya; Yasar Demirelli; Esad Koklu; Ulker Celik; Nuriye Tarakci; Didem Armangil; Emel Okulu; Fatma Narter; Birgul Mutlu; Mustafa Kurthan Mert; Ali Bulbul; Huseyin Selim Asker; Ozgun Uygur; Ilker Sait Uslu; Sabahattin Ertugrul; Cumhur Aydemir; Hasan Tolga Celik; Kazim Kucuktasci; Selda Arslan; Hacer Ergin; Aysegul Zenciroglu; Sadik Yurttutan; Aysen Orman; Oguz Tuncer; Beril Yasa; Betul Acunas; Sahin Takci; Zeynel Gokmen; Hilal Ozkan; Serdar Comert; Nuran Ustun; Mehmet Mutlu; Bilge Tanyeri Bayraktar; Leyla Bilgin; Funda Tuzun; Ozge Aydemir; Tugba Gursoy; Arzu Akdag; Asli Memisoglu; Emrah Can; Demet Terek; Serdar Beken; Ozden Turan; Nilufer Guzoglu; Rahmi Ors; Yusuf Kale; Berna Hekimoglu; Hakan Aylanc; Funda Eroglu; Suzan Sahin; Murat Konak; Dilek Sarici; Ilknur Kilic; Nilay Hakan
Journal:  PLoS One       Date:  2019-12-18       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.